Molecular Biology and Human Genetics Laboratory, Department of Zoology, The University of Burdwan, Golapbug Campus, Burdwan, 713101, West Bengal, India.
J Cancer Res Clin Oncol. 2014 Sep;140(9):1585-93. doi: 10.1007/s00432-014-1695-2. Epub 2014 May 8.
The objective was to study the gelatinolytic activity of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in preinvasive and invasive carcinoma of the uterine cervix. The expressions were analysed against different age groups, as to demonstrate whether the expression of MMP-2 and MMP-9 is an early or a late event during the progression of cervical cancer. Additionally, the diagnostic accuracy of MMP-2 and MMP-9 was evaluated with ROC curve.
A total number of 180 samples of cervical tissue were studied for MMP-2 and MMP-9 gelatinolytic activity. The cases were selected as to include 63 normal cases, 94 CIN cases and 23 cervical carcinoma cases. Among 94 CIN cases, 40 were CIN1, 26 were CIN2 and 28 were CIN3, as reported by histopathology. The gelatinolytic activities of MMP-2 and MMP-9 were evaluated by gelatin zymography in premenopausal and postmenopausal groups.
MMP-2 expressions (latent and active) were very low in control samples, followed by increase in CIN1, decrease in CIN2 and further increase in advance stages. MMP-9 had also shown the same expression pattern that of MMP-2. While comparing the expression of MMP-2 and MMP-9 in different age groups, we found initial CIN stages were prevalent in early age that expressed considerable amount of MMP-2 and MMP-9, and advance stages of carcinoma cervix were prevalent at an elderly age.
Both MMP-2 and MMP-9 have role in cancer progression and remodelling of the ectocervix. Although expression level varies intricately, a distinctive ROC curve demonstrated MMP-2 active form and MMP-9 form could be used in diagnostic purpose in detection of cervical lesion and cancer.
研究基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)在子宫颈癌前病变和浸润性癌中的明胶酶活性。分析了它们在不同年龄组中的表达情况,以证明 MMP-2 和 MMP-9 的表达是宫颈癌进展过程中的早期还是晚期事件。此外,还通过 ROC 曲线评估了 MMP-2 和 MMP-9 的诊断准确性。
共研究了 180 例宫颈组织样本的 MMP-2 和 MMP-9 明胶酶活性。选择的病例包括 63 例正常病例、94 例 CIN 病例和 23 例宫颈癌病例。94 例 CIN 病例中,组织病理学报告 40 例为 CIN1、26 例为 CIN2、28 例为 CIN3。通过明胶酶谱法在绝经前和绝经后组中评估 MMP-2 和 MMP-9 的明胶酶活性。
MMP-2(潜伏型和活性型)在对照样本中的表达非常低,随后 CIN1 增加,CIN2 减少,进展期进一步增加。MMP-9 也表现出与 MMP-2 相同的表达模式。在比较 MMP-2 和 MMP-9 在不同年龄组中的表达时,我们发现最初的 CIN 阶段在年轻时更为常见,表达相当数量的 MMP-2 和 MMP-9,而宫颈癌的晚期阶段则在老年时更为常见。
MMP-2 和 MMP-9 均在癌症进展和外宫颈重塑中发挥作用。虽然表达水平错综复杂,但独特的 ROC 曲线表明 MMP-2 活性形式和 MMP-9 形式可用于诊断目的,以检测宫颈病变和癌症。